These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1690422)

  • 21. Antimuscarinic effects of chloroquine in rat pancreatic acini.
    Habara Y; Williams JA; Hootman SR
    Biochem Biophys Res Commun; 1986 Jun; 137(2):664-9. PubMed ID: 2425800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rat pancreastatin inhibits both pancreatic exocrine and endocrine secretions in rats.
    Miyasaka K; Funakoshi A; Yasunami Y; Nakamura R; Kitani K; Tamamura H; Funakoshi S; Fujii N
    Regul Pept; 1990 Apr; 28(2):189-98. PubMed ID: 1693005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Islet amyloid polypeptide (IAPP;amylin) influences the endocrine but not the exocrine rat pancreas.
    Fehmann HC; Weber V; Göke R; Göke B; Eissele R; Arnold R
    Biochem Biophys Res Commun; 1990 Mar; 167(3):1102-8. PubMed ID: 1690993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of pancreastatin on pancreatic endocrine and exocrine secretion.
    Ishizuka J; Asada I; Poston GJ; Lluis F; Tatemoto K; Greeley GH; Thompson JC
    Pancreas; 1989; 4(3):277-81. PubMed ID: 2471966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of proglumide on cholecystokinin-8-induced exocrine and endocrine pancreatic responses in conscious sheep.
    Mineo H; Iwaki N; Kogishi K; Onaga T; Kato S; Zabielski R
    Comp Biochem Physiol A Physiol; 1997 Nov; 118(3):759-64. PubMed ID: 9406447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L364718, a new CCK antagonist, inhibits biological actions of CCK in conscious dogs.
    Hosotani R; Chowdhury P; McKay D; Rayford PL
    Peptides; 1987; 8(6):1061-4. PubMed ID: 3441445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exocrine effects of the CCK antagonist L-364,718 in canine pancreatic autografts.
    Garvin PJ; Niehoff ML; Burton FR; Dysarz FA; Meadow R; Solomon H
    J Surg Res; 1996 Feb; 61(1):256-9. PubMed ID: 8769975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose-dependent insulinotropic action of cholecystokinin and caerulein in the isolated perfused rat pancreas.
    Sakamoto C; Otsuki M; Ohki A; Yuu H; Maeda M; Yamasaki T; Baba S
    Endocrinology; 1982 Feb; 110(2):398-402. PubMed ID: 6173205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological profile of TP-680, a new cholecystokininA receptor antagonist.
    Akiyama T; Tachibana I; Hirohata Y; Shirohara H; Yamamoto M; Otsuki M
    Br J Pharmacol; 1996 Apr; 117(7):1558-64. PubMed ID: 8730754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCKA receptor antagonism inhibits mechanisms underlying CCK-8-stimulated insulin release in isolated rat islets.
    Karlsson S; Ahrén B
    Eur J Pharmacol; 1991 Sep; 202(2):253-7. PubMed ID: 1666367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of CCK antagonist L 364718 on meal-induced pancreatic secretion in rats.
    O'Rourke MF; Reidelberger RD; Solomon TE
    Am J Physiol; 1990 Feb; 258(2 Pt 1):G179-84. PubMed ID: 1689547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini.
    Talkad VD; Patto RJ; Metz DC; Turner RJ; Fortune KP; Bhat ST; Gardner JD
    Biochim Biophys Acta; 1994 Oct; 1224(1):103-16. PubMed ID: 7524683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new CCK-B/gastrin receptor antagonist acts as an agonist on the rat pancreas.
    Koop I; Eissele R; Richter S; Patberg H; Meyer F; Mössner J; Arnold R; Koop H
    Int J Pancreatol; 1994 Jun; 15(3):215-22. PubMed ID: 7523549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual effects of chlorobutanol on secretory response and intracellular Ca2+ dynamics in isolated pancreatic acini of the rat.
    Habara Y; Kanno T
    Br J Pharmacol; 1993 Jul; 109(3):685-92. PubMed ID: 7689400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metalloendopeptidase inhibitors and stimulus-secretion coupling in the mouse exocrine pancreas.
    Collins SP; Roberts ML
    Pancreas; 1990 Sep; 5(5):574-9. PubMed ID: 1700415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose-dependent insulinotropic action of cholecystokinin octapeptide in the isolated perfused rat pancreas.
    Müller MK; Demol P; Fladrich G; Goebell H; Pederson RA
    Digestion; 1983; 27(4):245-51. PubMed ID: 6317502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a new cholinergic agonist, aclatonium napadisilate, on exocrine and endocrine rat pancreas.
    Otsuki M; Nakamura T; Okabayashi Y; Fujii M; Tani S; Fujisawa T; Baba S
    Dig Dis Sci; 1989 Aug; 34(8):1249-56. PubMed ID: 2473869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of neuromedin B and neuromedin C on exocrine and endocrine rat pancreas.
    Otsuki M; Fujii M; Nakamura T; Tani S; Oka T; Yajima H; Baba S
    Am J Physiol; 1987 Apr; 252(4 Pt 1):G491-8. PubMed ID: 2436486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-364,718, a new CCK antagonist, inhibits postprandial pancreatic secretion and PP release in dogs.
    Hosotani R; Chowdhury P; Rayford PL
    Dig Dis Sci; 1989 Mar; 34(3):462-7. PubMed ID: 2646088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporine A inhibits protein-kinase-C-mediated amylase release from isolated rat pancreatic acini.
    Höcker M; Waschulewski IH; Kern HF; Domagk KA; Schwarzhoff R; Fölsch UR; Schmidt WE
    Digestion; 1994; 55(6):380-8. PubMed ID: 7535711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.